The German Diabetes Society (DDG) issued a warning concerning a rise in pregnancies among women using injectable medications ...

Type 2 diabetes is a chronic condition where the body becomes resistant to insulin or doesn't produce enough of it, leading ...

Evidence is mounting that new therapies already used to treat gut diseases, type 2 diabetes, and obesity may help people with alcohol use disorder (AUD).

Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...

Researchers explore the therapeutic potential and clinical insights of GP1-RAs in the management of metabolic ...

Altimmune is redefining success in both obesity and MASH to position Pemvidutide in blue ocean categories. Read why I rate ...

The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...

He cited a study that found that although the U.S. has the costliest healthcare system in the world, it ranks 42nd in life ...

FTC approves Novo Holdings' $16.5B Catalent acquisition. Deal includes selling 3 facilities to Novo Nordisk for $11B, despite ...

New research shows how weight loss meds like Wegovy are reshaping alcohol habits, offering new insights into addiction ...

For the first time in over a decade, obesity rates in the United States may finally be heading in the right direction and new weight loss drugs like semaglutide could be part of the reason why.

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) have competed for decades. In recent years, these two healthcare leaders ...